Skye also reported changes in waist circumference, a key secondary endpoint. Nimacimab plus semaglutide showed a least-means squared (SE) change of -11.26cm (1.16cm) in waist circumference versus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback